H. Elizabeth Broome - Concepedia

Author

H. Elizabeth Broome

University of California San Diego

Also Known As

H Broome, H E Broome, H Elizabeth Broome, H. Elizabeth Broome, H.Elizabeth Broome, Helen E. Broome

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of California San Diego Duke Medical Center Sanford Consortium for Regenerative Medicine La Jolla Institute for Immunology Singapore General Hospital

About

H. Elizabeth Broome is an author at University of California San Diego specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	982
2	Allergy	3	3	209
3	Health Sciences	2	2	133
4	Arts	1	1	18
5	Anatomy	1	1	18

H. Elizabeth Broome

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte Daniel E. Sabath, H. Elizabeth Broome, Michael B. Prystowsky Gene InflammationCytokineImmune Cell DevelopmentImmune RegulationImmunology	1990	383
A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study Andy C. Rawstron, Claudia Fazi, Andreas Agathangelidis, Leukemia	2015	235
Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. Xie Zhang, L Giangreco, H. Elizabeth Broome, The Journal of Experimental Medicine Lymphocyte DevelopmentT-regulatory CellImmunologyImmune RegulationCell Death	1995	165
Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal H. Elizabeth Broome, C M Dargan, S Krajewski, The Journal of Immunology	1995	164
Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia Bryan Zimdahl, Takahiro Ito, Allen Blevins, Nature Genetics Hematological MalignancyAsymmetric DivisionDevelopmental BiologyCell RegulationCell Division	2014	113
ROR1 is expressed on hematogones (non-neoplastic human B-lymphocyte precursors) and a minority of precursor-B acute lymphoblastic leukemia H. Elizabeth Broome, Laura Z. Rassenti, Huan‐You Wang, Leukemia Research Hematological MalignancyTumor BiologyMedicineHematologyPathology	2011	81
An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia Jeevisha Bajaj, Michael Hamilton, Yutaka Shima, Nature Cancer Key RegulatorMolecular BiologyGene EditingCrisprMyeloid Leukemia	2020	61
Copper deficiency‐induced anemia and neutropenia secondary to intestinal malabsorption Bruce A. Hayton, H. Elizabeth Broome, Rogério Lilenbaum American Journal of Hematology AnemiaIron MetabolismMedicinePartial GastrectomyHematology	1995	52
Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs H. Elizabeth Broome, Alice L. Yu, Mitch Diccianni, Leukemia Research Hematological MalignancyMixed-phenotype Acute LeukemiaImmunologyChemotherapeutic DrugsAdult T-cell Leukemia-lymphoma	2002	35
Apoptosis and Bcl-2 expression in cultured murine splenic T cells. H. Elizabeth Broome, C M Dargan, E F Bessent, PubMed T-regulatory CellApoptosisImmunologyImmune RegulationCell Death	1995	30

Page 1